Actuate Therapeutics, Inc. Shares Outstanding (Cover Page)
Actuate Therapeutics, Inc. (ACTU) had Shares Outstanding (Cover Page) of 24.01 million shares as of 2026-08-13, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-13: Entity Common Stock, Shares Outstanding 24.01M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 23.93M shares.
- 2026-03-25: Entity Common Stock, Shares Outstanding 23.71M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 23.24M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 24.01M shares 10-Q · filed 2026-08-14 |
| 2026-05-13 | 23.93M shares 10-Q · filed 2026-05-14 |
| 2026-03-25 | 23.71M shares 10-K · filed 2026-03-26 |
| 2025-11-12 | 23.24M shares 10-Q · filed 2025-11-13 |
| 2025-08-13 | 20.75M shares 10-Q · filed 2025-08-14 |
| 2025-05-14 | 19.62M shares 10-Q · filed 2025-05-15 |
| 2025-03-10 | 19.53M shares 10-K · filed 2025-03-13 |
| 2024-11-11 | 19.53M shares 10-Q · filed 2024-11-13 |
| 2024-09-23 | 19.53M shares 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |